fbpx

Parkinson’s Disease

147 results.

April 6, 2022 Top-line results reported from clinical trial of diabetes drug in Parkinson’s

This release has been republished from Cure Parkinson’s. Researchers from Cedars Sinai Hospital, Los Angeles, have presented their initial top line results of

April 1, 2022 Slowing or stopping Parkinson’s disease: Where are we?

If you read a lot about Parkinson’s disease, one term you’ll often see is “disease modification.” This bit of jargon has an important meaning —…

December 14, 2021 A year — and a quarter century — in review

As 2021 comes to a close, so too does Van Andel Institute’s celebration of our 25th anniversary. The Institute’s story began with a vision: to…

November 15, 2021 Graduate student spotlight: Investigating the links between the immune system and Parkinson’s disease

Throughout the year, we highlight Van Andel Institute Graduate School’s doctoral students. This month, we’re featuring Alysa Kasen, a Ph.D. student in the lab of Dr.…

October 26, 2021 Emory University, Van Andel Institute scientists receive $6 million grant to accelerate Parkinson’s disease research

NOTE: This release was originally published by Emory University. GRAND RAPIDS, Mich (Oct. 26, 2021) – Emory University researchers received a three-year, $6.3 million grant…

October 26, 2021 Van Andel Institute, Yale University and University of Pennsylvania scientists awarded grant from Aligning Science Across Parkinson’s

GRAND RAPIDS, Mich. (Oct. 26, 2021) — Scientists from Van Andel Institute, Yale University and University of Pennsylvania are recipients of a $9 million Collaborative Research Network grant…

October 8, 2021 2021 Tom Isaacs Award honors leading Parkinson’s expert

NOTE: This release has been republished with permission from Cure Parkinson’s. Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr. Camille Carroll,…